Operating Margin of Anika Therapeutics, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Anika Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Anika Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -11%, a 147% decline year-over-year.
  • Anika Therapeutics, Inc. annual Operating Margin for 2024 was -4%, a 708% decline from 2023.
  • Anika Therapeutics, Inc. annual Operating Margin for 2023 was 1%, a 78% decline from 2022.
  • Anika Therapeutics, Inc. annual Operating Margin for 2022 was 3%, a 82% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Anika Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -11% -34% -147% 01 Jul 2025 30 Sep 2025
Q2 2025 -8% -21% -162% 01 Apr 2025 30 Jun 2025
Q1 2025 -6% -16% -160% 01 Jan 2025 31 Mar 2025
Q4 2024 -4% -5% -708% 01 Oct 2024 31 Dec 2024
Q3 2024 24% +30% 01 Jul 2024 30 Sep 2024
Q2 2024 13% +18% 01 Apr 2024 30 Jun 2024
Q1 2024 10% +14% 01 Jan 2024 31 Mar 2024
Q4 2023 1% -3% -78% 01 Oct 2023 31 Dec 2023
Q3 2023 -6% +8% +57% 01 Jul 2023 30 Sep 2023
Q2 2023 -5% +5% +52% 01 Apr 2023 30 Jun 2023
Q1 2023 -5% -3% -217% 01 Jan 2023 31 Mar 2023
Q4 2022 3% +1% +82% 01 Oct 2022 31 Dec 2022
Q3 2022 -14% -10% -234% 01 Jul 2022 30 Sep 2022
Q2 2022 -10% +2% +14% 01 Apr 2022 30 Jun 2022
Q1 2022 -1% +25% +94% 01 Jan 2022 31 Mar 2022
Q4 2021 2% +23% 01 Oct 2021 31 Dec 2021
Q3 2021 -4% 0% +1.6% 01 Jul 2021 30 Sep 2021
Q2 2021 -11% -23% -198% 01 Apr 2021 30 Jun 2021
Q1 2021 -26% -55% -192% 01 Jan 2021 31 Mar 2021
Q4 2020 -22% -52% -173% 01 Oct 2020 31 Dec 2020
Q3 2020 -4% -39% -112% 01 Jul 2020 30 Sep 2020
Q2 2020 11% -21% -65% 01 Apr 2020 30 Jun 2020
Q1 2020 29% -4% -11% 01 Jan 2020 31 Mar 2020
Q4 2019 30% +9% +45% 01 Oct 2019 31 Dec 2019
Q3 2019 35% +15% +74% 01 Jul 2019 30 Sep 2019
Q2 2019 33% +11% +52% 01 Apr 2019 30 Jun 2019
Q1 2019 32% +5% +20% 01 Jan 2019 31 Mar 2019
Q4 2018 21% -20% -49% 01 Oct 2018 31 Dec 2018
Q3 2018 20% 01 Jul 2018 30 Sep 2018
Q2 2018 22% 01 Apr 2018 30 Jun 2018
Q1 2018 27% 01 Jan 2018 31 Mar 2018
Q4 2017 40% 01 Oct 2017 31 Dec 2017

Anika Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -4% -5% -708% 01 Jan 2024 31 Dec 2024
2023 1% -3% -78% 01 Jan 2023 31 Dec 2023
2022 3% +1% +82% 01 Jan 2022 31 Dec 2022
2021 2% +23% 01 Jan 2021 31 Dec 2021
2020 -22% -52% -173% 01 Jan 2020 31 Dec 2020
2019 30% +9% +45% 01 Jan 2019 31 Dec 2019
2018 21% -20% -49% 01 Jan 2018 31 Dec 2018
2017 40% -9% -18% 01 Jan 2017 31 Dec 2017
2016 49% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.